Translational Medicine of Aging

The official journal of the Asian Society for Aging Research

Translational Medicine of Aging is a peer-reviewed international journal publishing original works and reviews in the area of the fundamental biology of aging as well as applications and intervention in aging and aging associated disorders. This is the first journal to focus specifically on the translational aspects of aging, integrating basic research and clinical/experimental medicine.

The scope of the journal covers

cellular, biochemical and molecular biology of aging,
the physiology, immunology and endocrinology of aging,
the genetic and epigenetic regulation of aging and age-related diseases,
mechanisms and intervention of cellular senescence and stem cell aging,
computational and functional genomics of aging,
animal models of aging research,
drug screening of anti-aging chemicals and pharmacology,
population study of aging and longevity.

Clinical studies on intervention in aging-related diseases are also a preferred area for the journal. In addition, we welcome commentaries and concise reviews on recent advances in aging research, applications and intervention.

View full aims and scope

The Asian Society for Aging Research was established in April 2011 during the First Tri-Nation Aging meeting in Dong-guan, China. It was founded by three scientists Prof Zhongjun Zhou from The University of Hong Kong, Prof Isao Shimokawa from Nagasaki University, Japan, and Prof Eun Seong Hwang from University of Seoul, Korea. Since then the annual meetings have been held for 6 time in Japan, China and Korea. The official journal for ASAR is Translational Medicine of Aging, which is currently organized by two Editors in Chief, Prof Zhou Zhongju and Prof Matt Keaberlain from University of Washington in Seattle.

View full society description

Editor-in-Chief: Prof. Zhongjun Zhou, Prof. Matt Kaeberlein
View full editorial board

Imprint: KeAi

ISSN: 2468-5011

Recent Articles